Fig. 1 · Structure
Documents & Downloads
Efercoleukin alfa
IL2 Fusion Protein
Efercoleukin alfa is a recombinant fusion protein combining interleukin-2 (IL-2) with a human IgG1 Fc region. This compound specifically binds to the high-affinity IL-2 receptor alpha chain (CD25), enhancing its potential as an immunomodulatory agent. Efercoleukin alfa has applications in cancer immunotherapy and autoimmune disease research, facilitating the study of T cell proliferation and activation.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 2760549-52-6 |
| Applications | IL2 Fusion Protein |
| Molecular Weight | 93.436 kDa |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.